121 related articles for article (PubMed ID: 10403551)
21. Inhibiting effects of diethylmaleate or NH4Cl on NaHCO3, but not butylated hydroxyanisole, promotion of urinary bladder carcinogenesis in male F344 rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hagiwara A; Tanaka H; Tamano S; Imaida K; Takahashi S; Fukushima S
J Toxicol Sci; 1994 Nov; 19(4):189-95. PubMed ID: 7884829
[TBL] [Abstract][Full Text] [Related]
22. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
[TBL] [Abstract][Full Text] [Related]
23. Effect of continuous intravesical infusion of low-concentrated mitomycin-C on bladder carcinogenesis in rats treated with N-butyl-N-4-hydroxybutyl-nitrosamine.
Kawano S; Yano S; Sakamoto S; Ogata J
J Urol; 1988 Jun; 139(6):1343-6. PubMed ID: 3131548
[TBL] [Abstract][Full Text] [Related]
24. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
[TBL] [Abstract][Full Text] [Related]
25. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S
Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
[TBL] [Abstract][Full Text] [Related]
26. Rat urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine and N-methyl-N-nitrosourea.
Ozono S; Babaya K; Sasaki K; Okamoto S; Momose H; Fujimoto K; Tsumatani K; Yamaguchi H; Hirao Y; Okajima E
Urol Res; 1990; 18(5):323-6. PubMed ID: 2256233
[TBL] [Abstract][Full Text] [Related]
27. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemically demonstrated variation in expression of cathepsin E between uracil-induced papillomatosis and N-butyl-N-(4-hydroxybutyl)nitrosamine-induced preneoplastic and neoplastic changes in rat urinary bladder.
Yamamoto S; Yonezawa S; Ichinose M; Miki K; Masui T; Fukushima S; Inoue H; Tatematsu M
Virchows Arch; 1996 Mar; 427(6):589-94. PubMed ID: 8605570
[TBL] [Abstract][Full Text] [Related]
29. Effects of intravesical instillation of antitumor chemotherapeutic and immunotherapeutic agents on bladder lesion development in rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okamura T; Ohtani M; Inoue K; Fukushima S; Ohtaguro K; Kakizoe T
J Urol; 1987 Nov; 138(5):1305-7. PubMed ID: 2444722
[TBL] [Abstract][Full Text] [Related]
30. Effects of intravesical instillation of antitumor drugs on the induction of preneoplastic bladder lesions in rats.
Ohtani M; Fukushima S; Ito N; Koiso K; Niijima T
Cancer Chemother Pharmacol; 1983; 11 Suppl():S64-6. PubMed ID: 6416700
[TBL] [Abstract][Full Text] [Related]
31. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Grubbs CJ; Moon RC; Squire RA; Farrow GM; Stinson SF; Goodman DG; Brown CC; Sporn MB
Science; 1977 Nov; 198(4318):743-4. PubMed ID: 910158
[TBL] [Abstract][Full Text] [Related]
32. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
Kunze E; Schulz H; Adamek M; Gabius HJ
J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer.
Okamura T; Tozawa K; Yamada Y; Sakagami H; Ueda K; Kohri K
J Urol; 1996 Sep; 156(3):967-71. PubMed ID: 8709375
[TBL] [Abstract][Full Text] [Related]
34. Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment.
Okajima E; Ozono S; Endo T; Majima T; Tsutsumi M; Fukuda T; Akai H; Denda A; Hirao Y; Okajima E; Nishino H; Nir Z; Konishi Y
Jpn J Cancer Res; 1997 Jun; 88(6):543-52. PubMed ID: 9263531
[TBL] [Abstract][Full Text] [Related]
35. Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
Tatematsu M; Miyata Y; Mizutani M; Hananouchi M; Hirose M
Gan; 1977 Apr; 68(2):193-202. PubMed ID: 892293
[TBL] [Abstract][Full Text] [Related]
36. Anti-promoting effect of nordihydroguaiaretic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine and sodium saccharin-induced rat urinary bladder carcinogenesis.
Yu A; Hashimura T; Nishio Y; Kanamaru H; Fukuzawa S; Yoshida O
Jpn J Cancer Res; 1992 Sep; 83(9):944-8. PubMed ID: 1429204
[TBL] [Abstract][Full Text] [Related]
37. F344/Shi rats bearing type b catalase-1 locus are sensitive to sodium L-ascorbate promotion of two-stage urinary bladder carcinogenesis.
Mori S; Murai T; Hosono M; Yamashita H; Oohara T; Makino S; Doteuchi M; Fukushima S
Teratog Carcinog Mutagen; 1998; 18(1):27-33. PubMed ID: 9586768
[TBL] [Abstract][Full Text] [Related]
38. Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hagiwara A; Tamano S; Ogiso T; Asakawa E; Fukushima S
Jpn J Cancer Res; 1990 Dec; 81(12):1232-8. PubMed ID: 2125992
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Murasaki G; Miyata Y; Babaya K; Arai M; Fukushima S; Ito N
Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979
[TBL] [Abstract][Full Text] [Related]
40. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
Miyata Y; Fukushima S; Hirose M; Masui T; Ito N
Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
